On ECHEMI
Home > Drugs > Jiangsu Langou Pharmaceutical Co., Ltd.

Jiangsu Langou Pharmaceutical Co., Ltd.

  • Founded in:

    2013-06-21
  • Country:

    China China
  • Address:

    No. 1, Langou Road, Xuzhou Industrial Park, Jiangsu
  • Tax NO.:

    91320305071075704T
  • Registered Funds:

    100 million yuan
  • Email:

Related Drugs
Sodium Glucuronate Injection
The main ingredient is sodium glucuronate.
Name Description Content CAS NO. Registered Holders
D-Glucuronic acid sodium salt

After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.

More

After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.

14984-34-0 0
Sodium Glucuronate Injection
The main ingredient is sodium glucuronate.
Name Description Content CAS NO. Registered Holders
D-Glucuronic acid sodium salt

After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.

More

After entering the body, this product is converted into glucuronic acid under the action of enzymes and works to reduce the activity of liver amylase, prevent glycogenolysis, increase liver glycogen content, and reduce fat storage. This product can combine with hydroxyl or carboxyl-containing poisons in the liver and intestines to become low-toxic or non-toxic glucuronic acid conjugates and be excreted in the urine.

14984-34-0 0
Scopolamine Hydrobromide Injection
The chemical name of this product is: 6β,7β-epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate.
Name Description Content CAS NO. Registered Holders
6β,7β-Epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate

This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.

More

This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.

0
Scopolamine Hydrobromide Injection
The chemical name of this product is: 6β,7β-epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate.
Name Description Content CAS NO. Registered Holders
6β,7β-Epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate

This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.

More

This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.

0
Scopolamine Hydrobromide Injection
The chemical name of this product is: 6β,7β-epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate.
Name Description Content CAS NO. Registered Holders
6β,7β-Epoxy-1aH,5aH-tropane-3α-ol (mono) tropate hydrobromide trihydrate

This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.

More

This product is an anticholinergic drug with strong peripheral effects. The peripheral effects of this product are stronger than atropine but the duration is shorter. The central effects are mainly inhibitory. It can inhibit glandular secretion, relieve capillary spasm, improve microcirculation, dilate bronchi, relieve smooth muscle spasm; it has a sedative and hypnotic effect on the cerebral cortex and an excitatory effect on the respiratory center.

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.